Background & Sources: Long term outcome of Progressive Multifocal Leukoencephalopathy after Tysabri exposure

This page collects vetted references on medical safety, regulatory guidance, and clinical background for anyone researching this topic.

Detailed topic guide

Long term outcome of Progressive Multifocal Leukoencephalopathy after Tysabri exposure — Research Summary — detailed background and analysis.

U.S. Food and Drug Administration (FDA)

Reference: U.S. Food and Drug Administration (FDA)

Authoritative source for clinical, regulatory, and public-health background reading.

European Medicines Agency (EMA)

Reference: European Medicines Agency (EMA)

Authoritative source for clinical, regulatory, and public-health background reading.